Trial of Ebola drug shows improvement in US but is suspended in China
The first results from an international experimental US antiviral drug are promising, even as a trial of the same drug in China shuts down. More than half of a group of severely ill coronavirus patients from the US, Canada, Europe and Japan improved after taking remdesivir made by California-based Gilead Sciences. Originally developed as a … Read more